ZYUS Life Sciences Corporation
ZYUS.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 259.20K | 409.90K | 461.30K | 1.32M | 256.10K |
| Total Receivables | 281.40K | 248.60K | 218.50K | 254.40K | 299.80K |
| Inventory | 328.80K | 396.70K | 398.70K | 437.90K | 1.45M |
| Prepaid Expenses | 277.10K | 265.40K | 242.10K | 322.50K | 571.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.15M | 1.32M | 1.32M | 2.34M | 2.58M |
|
|
|||||
| Total Current Assets | 1.15M | 1.32M | 1.32M | 2.34M | 2.58M |
| Net Property, Plant & Equipment | 6.55M | 7.22M | 7.26M | 7.76M | 8.84M |
| Long-term Investments | -- | -- | -- | -- | 4.35M |
| Goodwill | -- | -- | -- | -- | 4.35M |
| Total Other Intangibles | -- | -- | -- | 0.00 | 9.28M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.90K | 99.00K | 105.80K | 105.60K | 112.50K |
| Total Assets | 7.79M | 8.64M | 8.69M | 10.20M | 25.15M |
|
|
|||||
| Total Accounts Payable | 6.22M | 6.28M | 5.25M | 3.12M | 6.77M |
| Total Accrued Expenses | -- | -- | -- | 2.34M | -- |
| Short-term Debt | 1.32M | 136.40K | 58.40K | 56.30K | 316.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.72M | 3.62M | 3.29M | 6.56M | 3.50M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.26M | 10.03M | 8.60M | 12.08M | 10.58M |
|
|
|||||
| Total Current Liabilities | 11.26M | 10.03M | 8.60M | 12.08M | 10.58M |
| Long-Term Debt | 4.37M | 4.21M | 3.79M | 257.80K | 316.80K |
| Short-term Debt | 1.32M | 136.40K | 58.40K | 56.30K | 316.10K |
| Capital Leases | 1.47M | 1.57M | 1.49M | 1.57M | 1.75M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 1.49M |
| Total Liabilities | 17.10M | 15.81M | 13.88M | 13.91M | 14.13M |
|
|
|||||
| Common Stock & APIC | 121.77M | 123.89M | 115.99M | 115.31M | 120.22M |
| Retained Earnings | -133.53M | -133.72M | -123.80M | -120.93M | -112.70M |
| Treasury Stock & Other | 2.45M | 2.66M | 2.62M | 1.90M | 3.50M |
| Total Common Equity | -9.31M | -7.17M | -5.20M | -3.71M | 11.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.31M | -7.17M | -5.20M | -3.71M | 11.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.31M | -7.17M | -5.20M | -3.71M | 11.02M |
|
|
|||||